Insurance for Life Science by Life Science Specialists

Whether in the United States or abroad, Berkley Life Sciences is solely dedicated to providing premiere insurance coverage for today’s top life sciences companies.

Download PDF

Who We Insure

We provide personalized property and casualty insurance products and services to the following life science markets:

Medical Device Companies

Companies that design, manufacture, and distribute medical instruments and devices for healthcare applications.

Medical Device Software Companies

Organizations that develop software solutions for use in union with medical devices to enhance functionality and patient outcomes.

Medical Drug Companies

Pharmaceutical firms involved in the research, development, manufacturing, and marketing of medications for treating various health conditions.

Biologic Companies

Companies that create biologically derived products, including vaccines, blood components, and gene therapies, for medical use.

Dietary Supplement Companies

Firms that produce and distribute vitamins, minerals, and other supplements intended to enhance health and wellness.

Medical Food Companies

Companies that develop and produce foods formulated explicitly for dietary management of diseases or conditions requiring medical supervision.

Cosmetic Drug Companies

Organizations that create products at the intersection of cosmetics and pharmaceuticals, designed to enhance appearance while providing therapeutic benefits.

Product Development Organizations

Companies offering specialized services in developing, testing, and regulatory approval of life science products.

Profit & Nonprofit R&D

Entities dedicated to conducting research in life sciences, ranging from private companies to academic and non-profit organizations.

Product Testing Laboratories

Laboratories specializing in the testing and validation of life science products, ensuring compliance with regulatory standards and safety requirements.

Medical Product Distributors

Companies that manage the distribution and supply chain logistics for a wide range of medical products, ensuring their availability to healthcare providers.

Drug Discovery Technology

Firms and organizations that develop technologies and methodologies to accelerate the identification and development of new pharmaceutical compounds.

Bioengineering

Companies and research institutions that apply biology and engineering principles to develop innovative solutions in healthcare, agriculture, and environmental management.

Health Informatics

Organizations specializing in the intersection of healthcare and information technology, providing solutions for managing and analyzing health data.

Non-Medical Biotechnology

Companies focused on biotechnology applications beyond healthcare, including agriculture, environmental management, and industrial processes.

Find a Berkley Life Sciences Agent

Ready for an insurance solution that is tailored to your life science business by life science specialists?

Find an Agent

The Latest in Life Science

Not Just a Claims Adjuster – A Conversation with Cynthia Khin

Recently, Magna Legal Services, a company that provides legal support and consulting services, interviewed Berkley Life Sciences Cynthia "Cindy" Khin, Life Sciences Casualty Resolution Director. The following is their conversation about Cindy’s career path and the importance of mock trials.

FDA Draft Guidance for Misinformation – Part 2

In a previous post, we discussed the FDA’s July 2024 Draft Guidance entitled "Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers" (the "Draft Guidance"). The Draft Guidance suggests a purportedly voluntary pathway for drug and device sponsors, manufacturers, distributors, and other stakeholders legally responsible for the labeling of approved/cleared medical products ("firms") to respond to internet-based posts and comments in a manner consistent with existing product labeling and advertising laws.

A surgeon handles sterilized medical equipment

Preventing Medical Device Shortages Through Improving the United States Sterilization Supply Chain

Both Ethylene Oxide (EtO) and gamma radiation are highly effective sterilizers for medical devices, but they face significant supply chain vulnerabilities that have already led to shortages within the United States. To mitigate these risks and bolster the sterilization supply chain, the FDA recently approved a new “Established Category A” sterilization method and implemented three key programs designed to encourage medical device manufacturers to adopt alternative methods, all within the last five years (FDA, 2024).